Safety of Tramadol and Gabapentin in Chronic Liver Disease Stage 4

Tramadol in CLD4

Tramadol is primarily metabolized in the liver, and its bioavailability increases 2-3 fold in patients with liver cirrhosis, requiring significant dose adjustment in advanced liver disease 1, 2
For patients with advanced cirrhosis (CLD4), no more than 50 mg of tramadol should be administered within 12 hours 1
Tramadol should not be used with medications that affect serotonin metabolism (SSRIs, SNRIs, TCAs) due to increased risk of seizures in liver disease patients 1

Acetaminophen remains safe at reduced doses (2-3g/day) in patients with liver cirrhosis 1, 2
Fentanyl has a favorable safety profile in liver disease due to its metabolism not producing toxic metabolites 3
Hydromorphone may be considered as its half-life remains relatively stable even in patients with liver dysfunction 3
NSAIDs should be strictly avoided in CLD4 patients due to risks of renal failure, GI bleeding, and decompensation 1, 2